×
Phreesia Receivables 2019-2025 | PHR
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Phreesia receivables from 2019 to 2025. Receivables can be defined as the total amount of collectibles for a company
View More
Phreesia Receivables 2019-2025 | PHR
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Phreesia receivables from 2019 to 2025. Receivables can be defined as the total amount of collectibles for a company
Related Stocks
Company Name
Market
Cap
Veeva Systems (VEEV)
$47.5B
Hims & Hers Health (HIMS)
$12.9B
Doximity (DOCS)
$11.4B
Tempus AI (TEM)
$11.2B
IRhythm Technologies (IRTC)
$4.3B
Inspire Medical Systems (INSP)
$3.8B
Hinge Health (HNGE)
$3.6B
Privia Health (PRVA)
$2.4B
10x Genomics (TXG)
$1.7B
Schrodinger (SDGR)
$1.6B
Azenta (AZTA)
$1.6B
Enovis (ENOV)
$1.6B
Clover Health Investments (CLOV)
$1.5B
Omnicell (OMCL)
$1.3B
Evolent Health (EVH)
$1.2B
Claritev (CTEV)
$652M
Fulgent Genetics (FLGT)
$559M
Standard BioTools (LAB)
$532M
Veradigm (MDRX)
$503M
Butterfly Network (BFLY)
$487M
Talkspace (TALK)
$421M
TruBridge (TBRG)
$353M
Outset Medical (OM)
$328M
Health Catalyst (HCAT)
$270M
Nyxoah SA (NYXH)
$258M
SOPHiA GENETICS SA (SOPH)
$240M
CapsoVision (CV)
$185M
Zepp Health (ZEPP)
$161M
KORU Medical Systems (KRMD)
$160M
American Well (AMWL)
$140M